{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T01:29:17Z","timestamp":1789003757484,"version":"build-2803163510"},"reference-count":92,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,10,25]],"date-time":"2023-10-25T00:00:00Z","timestamp":1698192000000},"content-version":"am","delay-in-days":328,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01 HL 122596"],"award-info":[{"award-number":["R01 HL 122596"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01 HL124021"],"award-info":[{"award-number":["R01 HL124021"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000968","name":"American Heart Association","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000968","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000001","name":"National Science Foundation","doi-asserted-by":"publisher","award":["2145877"],"award-info":[{"award-number":["2145877"]}],"id":[{"id":"10.13039\/100000001","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Controlled Release"],"published-print":{"date-parts":[[2022,12]]},"DOI":"10.1016\/j.jconrel.2022.10.024","type":"journal-article","created":{"date-parts":[[2022,10,25]],"date-time":"2022-10-25T17:46:43Z","timestamp":1666720003000},"page":"242-255","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"special_numbering":"C","title":["In silico identification and synthesis of a multi-drug loaded MOF for treating tuberculosis"],"prefix":"10.1016","volume":"352","author":[{"given":"Abhinav P.","family":"Acharya","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kutay B.","family":"Sezginel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hannah P.","family":"Gideon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashlee C.","family":"Greene","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harrison D.","family":"Lawson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sahil","family":"Inamdar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy J.","family":"Fraser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kush V.","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathaniel L.","family":"Rosi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen Y.","family":"Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"JoAnne L.","family":"Flynn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher E.","family":"Wilmer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven R.","family":"Little","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jconrel.2022.10.024_bb0005","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.0040238","article-title":"Patient adherence to tuberculosis treatment: a systematic review of qualitative research","volume":"4","author":"Munro","year":"2007","journal-title":"PLoS Med."},{"key":"10.1016\/j.jconrel.2022.10.024_bb0010","first-page":"320","article-title":"A review of compliance to anti tuberculosis treatment and risk factors for defaulting treatment in sub Saharan Africa","volume":"10","author":"Castelnuovo","year":"2010","journal-title":"Afr. Health Sci."},{"key":"10.1016\/j.jconrel.2022.10.024_bb0015","first-page":"307","article-title":"Factors affecting patient compliance with anti-tuberculosis chemotherapy using the directly observed treatment, short-course strategy (DOTS)","volume":"6","author":"O\u2019Boyle","year":"2002","journal-title":"Int. J. Tuberc. Lung Dis."},{"key":"10.1016\/j.jconrel.2022.10.024_bb0020","first-page":"369","article-title":"Factors contributing to poor compliance with anti-TB treatment among tuberculosis patients","volume":"32","author":"Naing","year":"2001","journal-title":"Southeast Asian J. Trop. Med. Public Health"},{"key":"10.1016\/j.jconrel.2022.10.024_bb0025","doi-asserted-by":"crossref","first-page":"269","DOI":"10.2147\/TCRM.S1458","article-title":"Factors affecting therapeutic compliance: a review from the patient\u2019s perspective","volume":"4","author":"Lin","year":"2008","journal-title":"Ther. Clin. Risk Manag."},{"key":"10.1016\/j.jconrel.2022.10.024_bb0030","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1056\/NEJMra1205429","article-title":"Tuberculosis, drug resistance, and the history of modern medicine","volume":"367","author":"Keshavjee","year":"2012","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jconrel.2022.10.024_bb0035","doi-asserted-by":"crossref","first-page":"S195","DOI":"10.1086\/651491","article-title":"Extensively drug-resistant tuberculosis: \u201cThere must be some kind of way out of here\u201d","volume":"50","author":"Cegielski","year":"2010","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.jconrel.2022.10.024_bb0040","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1001\/jama.1996.03530300036037","article-title":"Origin and interstate spread of a New York City multidrug-resistant Mycobacterium tuberculosis clone family","volume":"275","author":"Bifani","year":"1996","journal-title":"JAMA: J. Am. Med. Assoc."},{"key":"10.1016\/j.jconrel.2022.10.024_bb0045","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1128\/AAC.05208-11","article-title":"Pharmacokinetic evaluation of the penetration of antituberculosis","volume":"56","author":"Kjellsson","year":"2012","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.jconrel.2022.10.024_bb0050","doi-asserted-by":"crossref","DOI":"10.1111\/imr.12252","article-title":"Heterogeneity in tuberculosis pathology, microenvironments and therapeutic responses","author":"Lenaerts","year":"2015","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.jconrel.2022.10.024_bb0055","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1111\/bcp.12885","article-title":"Mechanism of isoniazid-induced hepatotoxicity: then and now","volume":"81","author":"Metushi","year":"2016","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.jconrel.2022.10.024_bb0060","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.jceh.2012.12.001","article-title":"Hepatotoxicity related to anti-tuberculosis drugs: mechanisms and management","volume":"3","author":"Ramappa","year":"2013","journal-title":"J. Clin. Exp. Hepatol."},{"key":"10.1016\/j.jconrel.2022.10.024_bb0065","doi-asserted-by":"crossref","first-page":"2535","DOI":"10.1128\/AAC.06049-11","article-title":"Targeted intracellular delivery of antituberculosis drugs to Mycobacterium tuberculosis-infected macrophages via functionalized mesoporous silica nanoparticles","volume":"56","author":"Clemens","year":"2012","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.jconrel.2022.10.024_bb0070","doi-asserted-by":"crossref","first-page":"1816","DOI":"10.1016\/j.addr.2013.07.020","article-title":"Nanotechnology and pulmonary delivery to overcome resistance in infectious diseases","volume":"65","author":"Andrade","year":"2013","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2022.10.024_bb0075","first-page":"3043","article-title":"Poly(lactide-co-glycolide)-rifampicin nanoparticles efficiently clear Mycobacterium bovis BCG infection in macrophages and remain membrane-bound in phago-lysosomes","volume":"126","author":"Kalluru","year":"2013","journal-title":"J. Cell Sci."},{"key":"10.1016\/j.jconrel.2022.10.024_bb0080","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.jconrel.2007.01.013","article-title":"Optimum conditions for efficient phagocytosis of rifampicin-loaded PLGA microspheres by alveolar macrophages","volume":"119","author":"Hirota","year":"2007","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2022.10.024_bb0085","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1586\/erm.09.15","article-title":"Current advances in research and clinical applications of PLGA-based nanotechnology","volume":"9","author":"L\u00fc","year":"2009","journal-title":"Expert. Rev. Mol. Diagn."},{"key":"10.1016\/j.jconrel.2022.10.024_bb0090","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2016.00185","article-title":"Bioerodable PLGA-based microparticles for producing sustained-release drug formulations and strategies for improving drug loading","volume":"7","author":"Han","year":"2016","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.jconrel.2022.10.024_bb0095","first-page":"221","article-title":"Improved drug loading and antibacterial activity of minocycline-loaded PLGA nanoparticles prepared by solid\/oil\/water ion pairing method","volume":"7","author":"Kashi","year":"2012","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.jconrel.2022.10.024_bb0100","doi-asserted-by":"crossref","first-page":"4723","DOI":"10.1039\/C5TB00515A","article-title":"Positive charge of \u201csticky\u201d peptides and proteins impedes release from negatively charged PLGA matrices","volume":"3","author":"Balmert","year":"2015","journal-title":"J. Mater. Chem. B"},{"key":"10.1016\/j.jconrel.2022.10.024_bb0105","doi-asserted-by":"crossref","first-page":"4168","DOI":"10.1016\/j.biomaterials.2009.04.032","article-title":"A high-throughput microparticle microarray platform for dendritic cell-targeting vaccines","volume":"30","author":"Acharya","year":"2009","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2022.10.024_bb0110","doi-asserted-by":"crossref","DOI":"10.1002\/adfm.201604366","article-title":"Localized multi-component delivery platform generates local and systemic anti-tumor immunity","author":"Acharya","year":"2017","journal-title":"Adv. Funct. Mater."},{"key":"10.1016\/j.jconrel.2022.10.024_bb0115","doi-asserted-by":"crossref","DOI":"10.1039\/C5TB01754H","article-title":"A cell-based microarray to investigate combinatorial effects of microparticle-encapsulated adjuvants on dendritic cell activation","author":"Acharya","year":"2016","journal-title":"J. Mater. Chem. B"},{"key":"10.1016\/j.jconrel.2022.10.024_bb0120","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2022.114242","article-title":"Drug delivery for metabolism targeted cancer immunotherapy","volume":"184","author":"Khodaei","year":"2022","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2022.10.024_bb0125","doi-asserted-by":"crossref","DOI":"10.1039\/D0TB00790K","article-title":"Metabolite releasing polymers control dendritic cell function by modulating their energy metabolism","author":"Mangal","year":"2020","journal-title":"J. Mater. Chem. B"},{"key":"10.1016\/j.jconrel.2022.10.024_bb0130","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2021.121079","article-title":"Inhibition of glycolysis in the presence of antigen generates suppressive antigen-specific responses and restrains rheumatoid arthritis in mice","volume":"277","author":"Mangal","year":"2021","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2022.10.024_bb0135","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1038\/nchem.1192","article-title":"Large-scale screening of hypothetical metal-organic frameworks","volume":"4","author":"Wilmer","year":"2012","journal-title":"Nat. Chem."},{"key":"10.1016\/j.jconrel.2022.10.024_bb0140","doi-asserted-by":"crossref","first-page":"4497","DOI":"10.1039\/C7CE00290D","article-title":"Discovery of hypothetical hetero-interpenetrated MOFs with arbitrarily dissimilar topologies and unit cell shapes","volume":"19","author":"Sezginel","year":"2017","journal-title":"CrystEngComm."},{"key":"10.1016\/j.jconrel.2022.10.024_bb0145","doi-asserted-by":"crossref","first-page":"6185","DOI":"10.1021\/cm502594j","article-title":"Computation-ready, experimental metal-organic frameworks: a tool to enable high-throughput screening of nanoporous crystals","volume":"26","author":"Chung","year":"2014","journal-title":"Chem. Mater."},{"key":"10.1016\/j.jconrel.2022.10.024_bb0150","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1080\/08927022.2015.1010082","article-title":"RASPA: molecular simulation software for adsorption and diffusion in flexible nanoporous materials","volume":"42","author":"Dubbeldam","year":"2016","journal-title":"Mol. Simul."},{"key":"10.1016\/j.jconrel.2022.10.024_bb0155","series-title":"Employing Feature Selection Algorithms to Determine the Immune State of Mice with Rheumatoid Arthritis","author":"Colbert","year":"2022"},{"key":"10.1016\/j.jconrel.2022.10.024_bb0160","doi-asserted-by":"crossref","first-page":"7950","DOI":"10.1016\/j.biomaterials.2013.07.011","article-title":"In silico design of anti-atherogenic biomaterials","volume":"34","author":"Lewis","year":"2013","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2022.10.024_bb0165","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.actbio.2015.09.009","article-title":"High-throughput screening approaches and combinatorial development of biomaterials using microfluidics","volume":"34","author":"Barata","year":"2016","journal-title":"Acta Biomater."},{"key":"10.1016\/j.jconrel.2022.10.024_bb0170","doi-asserted-by":"crossref","first-page":"5666","DOI":"10.1021\/ja049408c","article-title":"Hydrogen sorption in functionalized metal-organic frameworks","volume":"126","author":"Rowsell","year":"2004","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.jconrel.2022.10.024_bb0175","doi-asserted-by":"crossref","first-page":"8069","DOI":"10.1021\/ic901056d","article-title":"Magnesium-based 3D metal-organic framework exhibiting hydrogen-sorption hysteresis","volume":"48","author":"Guo","year":"2009","journal-title":"Inorg. Chem."},{"key":"10.1016\/j.jconrel.2022.10.024_bb0180","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms8240","article-title":"Biomimetic mineralization of metal-organic frameworks as protective coatings for biomacromolecules","volume":"6","author":"Liang","year":"2015","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jconrel.2022.10.024_bb0185","doi-asserted-by":"crossref","first-page":"2111","DOI":"10.1039\/b502512e","article-title":"Templated metal-organic frameworks: synthesis, structures, thermal properties and solid-state transformation of two novel calcium-adipate frameworks","author":"Lill","year":"2005","journal-title":"Dalton Trans."},{"key":"10.1016\/j.jconrel.2022.10.024_bb0190","doi-asserted-by":"crossref","first-page":"2259","DOI":"10.1128\/AAC.05993-11","article-title":"An isoniazid analogue promotes Mycobacterium tuberculosis-nanoparticle interactions and enhances bacterial killing by macrophages","volume":"56","author":"de Faria","year":"2012","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.jconrel.2022.10.024_bb0195","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/S0378-5173(02)00034-0","article-title":"Role of poly [dl-lactide-co-glycolide] in development of a sustained oral delivery system for antitubercular drug(s)","volume":"239","author":"Ain","year":"2002","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2022.10.024_bb0200","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1093\/jac\/dkg477","article-title":"Poly (DL-lactide-co-glycolide) nanoparticle-based inhalable sustained drug delivery system for experimental tuberculosis","volume":"52","author":"Pandey","year":"2003","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.jconrel.2022.10.024_bb0205","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1093\/jac\/47.6.829","article-title":"Chemotherapy of Mycobacterium tuberculosis infections in mice with a combination of isoniazid and rifampicin entrapped in poly (DL-lactide-co-glycolide) microparticles","volume":"47","author":"Dutt","year":"2001","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.jconrel.2022.10.024_bb0210","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1038\/s41385-019-0195-8","article-title":"Neutrophils express pro- and anti-inflammatory cytokines in granulomas from Mycobacterium tuberculosis-infected cynomolgus macaques","volume":"12","author":"Gideon","year":"2019","journal-title":"Mucosal Immunol."},{"key":"10.1016\/j.jconrel.2022.10.024_bb0215","doi-asserted-by":"crossref","DOI":"10.1126\/science.1230444","article-title":"The chemistry and applications of metal-organic frameworks","volume":"341","author":"Furukawa","year":"2013","journal-title":"Science"},{"key":"10.1016\/j.jconrel.2022.10.024_bb0220","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.micromeso.2004.03.034","article-title":"Metal-organic frameworks: a new class of porous materials","volume":"73","author":"Rowsell","year":"2004","journal-title":"Microporous Mesoporous Mater."},{"key":"10.1016\/j.jconrel.2022.10.024_bb0225","doi-asserted-by":"crossref","first-page":"4966","DOI":"10.1002\/anie.200703934","article-title":"Gas storage in nanoporous materials","volume":"47","author":"Morris","year":"2008","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.jconrel.2022.10.024_bb0230","doi-asserted-by":"crossref","first-page":"6260","DOI":"10.1002\/anie.201000048","article-title":"BioMOFs: metal-organic frameworks for biological and medical applications","volume":"49","author":"McKinlay","year":"2010","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.jconrel.2022.10.024_bb0235","doi-asserted-by":"crossref","first-page":"11688","DOI":"10.1021\/ja403810k","article-title":"Stepwise ligand exchange for the preparation of a family of mesoporous MOFs","volume":"135","author":"Li","year":"2013","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.jconrel.2022.10.024_bb0240","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1002\/jbm.a.35995","article-title":"Metal-organic-frameworks for biomedical applications in drug delivery, and as MRI contrast agents","volume":"105","author":"Chowdhury","year":"2017","journal-title":"J. Biomed. Mater. Res. A"},{"key":"10.1016\/j.jconrel.2022.10.024_bb0245","doi-asserted-by":"crossref","first-page":"5974","DOI":"10.1002\/anie.200601878","article-title":"Metal-organic frameworks as efficient materials for drug delivery","volume":"45","author":"Horcajada","year":"2006","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.jconrel.2022.10.024_bb0250","doi-asserted-by":"crossref","first-page":"6185","DOI":"10.1021\/cm502594j","article-title":"Computation-ready, experimental metal-organic frameworks: a tool to enable high-throughput screening of nanoporous crystals","volume":"26","author":"Chung","year":"2014","journal-title":"Chem. Mater."},{"key":"10.1016\/j.jconrel.2022.10.024_bb0255","doi-asserted-by":"crossref","first-page":"5666","DOI":"10.1021\/ja049408c","article-title":"Hydrogen sorption in functionalized metal-organic frameworks","volume":"126","author":"Rowsell","year":"2004","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.jconrel.2022.10.024_bb0260","doi-asserted-by":"crossref","first-page":"8069","DOI":"10.1021\/ic901056d","article-title":"Magnesium-based 3D metal-organic framework exhibiting hydrogen-sorption hysteresis","volume":"48","author":"Guo","year":"2009","journal-title":"Inorg. Chem."},{"key":"10.1016\/j.jconrel.2022.10.024_bb0265","doi-asserted-by":"crossref","first-page":"2111","DOI":"10.1039\/b502512e","article-title":"Templated metal-organic frameworks: synthesis, structures, thermal properties and solid-state transformation of two novel calcium-adipate frameworks","author":"De Lill","year":"2005","journal-title":"Dalton Trans."},{"key":"10.1016\/j.jconrel.2022.10.024_bb0270","doi-asserted-by":"crossref","first-page":"8376","DOI":"10.1021\/ja902972w","article-title":"Cation-triggered drug release from a porous zinc-adeninate metal-organic framework","volume":"131","author":"An","year":"2009","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.jconrel.2022.10.024_bb0275","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms1618","article-title":"Metal-adeninate vertices for the construction of an exceptionally porous metal-organic framework","volume":"3","author":"An","year":"2012","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jconrel.2022.10.024_bb0280","doi-asserted-by":"crossref","first-page":"17010","DOI":"10.1002\/chem.201501560","article-title":"Drug release properties of a series of adenine-based metal-organic frameworks","volume":"21","author":"Oh","year":"2015","journal-title":"Chem. Eur. J."},{"key":"10.1016\/j.jconrel.2022.10.024_bb0285","doi-asserted-by":"crossref","first-page":"1868","DOI":"10.1126\/science.276.5320.1868","article-title":"Large porous particles for pulmonary drug delivery","volume":"276","author":"Edwards","year":"1997","journal-title":"Science"},{"key":"10.1016\/j.jconrel.2022.10.024_bb0290","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.addr.2016.04.012","article-title":"The formulation of nanomedicines for treating tuberculosis","volume":"102","author":"Costa","year":"2016","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2022.10.024_bb0295","doi-asserted-by":"crossref","DOI":"10.1164\/ajrccm\/138.4.999","article-title":"Minimal inhibitory concentrations of isoniazid, rifampin, ethambutol, and streptomycin against Mycobacterium tuberculosis strains isolated before treatment of patients in Taiwan","author":"Suo","year":"1988","journal-title":"Am. Rev. Respir. Dis."},{"key":"10.1016\/j.jconrel.2022.10.024_bb0300","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.32.7.1002","article-title":"Determination of pyrazinamide MICs for Mycobacterium tuberculosis at different pHs by the radiometric method","author":"Salfinger","year":"1988","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.jconrel.2022.10.024_bb0305","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.3390\/nano9081167","article-title":"Spray-Dried, nanoencapsulated, multi-drug anti-tuberculosis therapy aimed at once weekly administration for the duration of treatment","volume":"9","author":"Kalombo","year":"2019","journal-title":"Nanomaterials"},{"key":"10.1016\/j.jconrel.2022.10.024_bb0310","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1007\/s10965-009-9320-9","article-title":"Nanoparticles composed of PLGA and hyperbranched poly (amine-ester) as a drug carrier","volume":"17","author":"Wang","year":"2010","journal-title":"J. Polym. Res."},{"key":"10.1016\/j.jconrel.2022.10.024_bb0315","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/j.msec.2015.08.055","article-title":"Lower cytotoxicity, high stability, and long-term antibacterial activity of a poly(methacrylic acid)\/isoniazid\/rifampin nanogel against multidrug-resistant intestinal Mycobacterium tuberculosis","volume":"58","author":"Chen","year":"2016","journal-title":"Mater. Sci. Eng. C"},{"key":"10.1016\/j.jconrel.2022.10.024_bb0320","doi-asserted-by":"crossref","first-page":"11739","DOI":"10.1021\/acs.inorgchem.1c00538","article-title":"Breast cancer targeting of a drug delivery system through postsynthetic modification of curcumin@N 3 -bio-MOF-100 via click chemistry","volume":"60","author":"Alves","year":"2021","journal-title":"Inorg. Chem."},{"key":"10.1016\/j.jconrel.2022.10.024_bb0325","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1126\/science.1174294","article-title":"Cell growth and size homeostasis in proliferating animal cells","volume":"325","author":"Tzur","year":"2009","journal-title":"Science"},{"key":"10.1016\/j.jconrel.2022.10.024_bb0330","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.jconrel.2007.03.022","article-title":"Particle shape: a new design parameter for micro- and nanoscale drug delivery carriers","volume":"121","author":"Champion","year":"2007","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2022.10.024_bb0335","doi-asserted-by":"crossref","first-page":"12420","DOI":"10.1073\/pnas.1635213100","article-title":"The primary mechanism of attenuation of bacillus Calmette\u2013Gu\u00e9rin is a loss of secreted lytic function required for invasion of lung interstitial tissue","volume":"100","author":"Hsu","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jconrel.2022.10.024_bb0340","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1189\/jlb.0505250","article-title":"Virulent clinical isolates of Mycobacterium tuberculosis grow rapidly and induce cellular necrosis but minimal apoptosis in murine macrophages","volume":"79","author":"Park","year":"2006","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.jconrel.2022.10.024_bb0345","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2016.01562","article-title":"Mycobacteria clumping increase their capacity to damage macrophages","volume":"7","author":"Brambilla","year":"2016","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.jconrel.2022.10.024_bb0350","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.jconrel.2022.01.030","article-title":"Particle uptake driven phagocytosis in macrophages and neutrophils enhances bacterial clearance","volume":"343","author":"Sharma","year":"2022","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2022.10.024_bb0355","first-page":"93","article-title":"Development of drug resistance to rifampicin","volume":"14","author":"Manten","year":"1969","journal-title":"Chemotherapy"},{"key":"10.1016\/j.jconrel.2022.10.024_bb0360","article-title":"Studies on the treatment of tuberculosis undertaken by the British medical research council tuberculosis units, 1946-1986, with relevant subsequent publications","volume":"3","author":"Fox","year":"1999","journal-title":"Int. J. Tuberc. Lung Dis."},{"key":"10.1016\/j.jconrel.2022.10.024_bb0365","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1038\/nm0696-662","article-title":"Mutations in pncA, a gene encoding pyrazinamidase\/nicotinamidase, cause resistance to the antituberculous drug pyrazinamide in tubercle bacillus","volume":"2","author":"Scorpio","year":"1996","journal-title":"Nat. Med."},{"key":"10.1016\/j.jconrel.2022.10.024_bb0370","doi-asserted-by":"crossref","first-page":"4433","DOI":"10.1021\/acsomega.9b03523","article-title":"Formulation and intracellular trafficking of lipid\u2013drug conjugate nanoparticles containing a hydrophilic antitubercular drug for improved intracellular delivery to human macrophages","volume":"5","author":"Pandit","year":"2020","journal-title":"ACS Omega"},{"key":"10.1016\/j.jconrel.2022.10.024_bb0375","doi-asserted-by":"crossref","first-page":"2535","DOI":"10.1128\/AAC.06049-11","article-title":"Targeted intracellular delivery of antituberculosis drugs to Mycobacterium tuberculosis-infected macrophages via functionalized mesoporous silica nanoparticles","volume":"56","author":"Clemens","year":"2012","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.jconrel.2022.10.024_bb0380","doi-asserted-by":"crossref","first-page":"3816","DOI":"10.1038\/s41467-021-24127-3","article-title":"Intracellular localisation of Mycobacterium tuberculosis affects efficacy of the antibiotic pyrazinamide","volume":"12","author":"Santucci","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jconrel.2022.10.024_bb0385","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1038\/nrmicro3200","article-title":"The path of anti-tuberculosis drugs: from blood to lesions to mycobacterial cells","volume":"12","author":"Dartois","year":"2014","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.jconrel.2022.10.024_bb0390","doi-asserted-by":"crossref","DOI":"10.1016\/j.dib.2019.103953","article-title":"Protein profile of different cellular fractions from Mycobacterium tuberculosis strains after exposure to isoniazid","volume":"24","author":"Nieto Ramirez","year":"2019","journal-title":"Data Brief"},{"key":"10.1016\/j.jconrel.2022.10.024_bb0395","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1038\/nrmicro3200","article-title":"The path of anti-tuberculosis drugs: from blood to lesions to mycobacterial cells","volume":"12","author":"Dartois","year":"2014","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.jconrel.2022.10.024_bb0400","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.jconrel.2014.05.038","article-title":"Respirable nanocarriers as a promising strategy for antitubercular drug delivery","volume":"187","author":"Mehanna","year":"2014","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2022.10.024_bb0405","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/j.ijpharm.2014.12.009","article-title":"Pulmonary drug delivery systems for tuberculosis treatment","volume":"478","author":"Pham","year":"2015","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2022.10.024_bb0410","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.jconrel.2015.11.018","article-title":"Inhaled drug treatment for tuberculosis: past progress and future prospects","volume":"240","author":"Hickey","year":"2016","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2022.10.024_bb0415","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejpb.2021.02.011","article-title":"Pharmacokinetics of rifampicin after repeated intra-tracheal administration of amorphous and crystalline powder formulations to Sprague Dawley rats","volume":"162","author":"Khadka","year":"2021","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.jconrel.2022.10.024_bb0420","doi-asserted-by":"crossref","DOI":"10.1016\/j.tube.2021.102081","article-title":"Inhalable particles containing isoniazid and rifabutin as adjunct therapy for safe, efficacious and relapse-free cure of experimental animal tuberculosis in one month","volume":"128","author":"Singh","year":"2021","journal-title":"Tuberculosis"},{"key":"10.1016\/j.jconrel.2022.10.024_bb0425","doi-asserted-by":"crossref","first-page":"5974","DOI":"10.1002\/anie.200601878","article-title":"Metal-organic frameworks as efficient materials for drug delivery","volume":"45","author":"Horcajada","year":"2006","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.jconrel.2022.10.024_bb0430","doi-asserted-by":"crossref","first-page":"2202604","DOI":"10.1002\/smll.202202604","article-title":"Radicals scavenging MOFs enabling targeting delivery of siRNA for rheumatoid arthritis therapy","volume":"18","author":"Guo","year":"2022","journal-title":"Small"},{"key":"10.1016\/j.jconrel.2022.10.024_bb0435","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2022.121472","article-title":"MOF@COF nanocapsule for the enhanced microwave thermal-dynamic therapy and anti-angiogenesis of colorectal cancer","volume":"283","author":"Li","year":"2022","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2022.10.024_bb0440","doi-asserted-by":"crossref","first-page":"2688","DOI":"10.1038\/s41467-022-30436-y","article-title":"Multifunctional metal-organic framework-based nanoreactor for starvation\/oxidation improved indoleamine 2,3-dioxygenase-blockade tumor immunotherapy","volume":"13","author":"Dai","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jconrel.2022.10.024_bb0445","doi-asserted-by":"crossref","first-page":"1907625","DOI":"10.1002\/adfm.201907625","article-title":"Assembly of molecular building blocks into integrated complex functional molecular systems: structuring matter made to order","volume":"30","author":"Hassan","year":"2020","journal-title":"Adv. Funct. Mater."},{"key":"10.1016\/j.jconrel.2022.10.024_bb0450","doi-asserted-by":"crossref","first-page":"1975","DOI":"10.1080\/03639045.2018.1506472","article-title":"Formulation, optimization, and characterization of rifampicin-loaded solid lipid nanoparticles for the treatment of tuberculosis","volume":"44","author":"Chokshi","year":"2018","journal-title":"Drug Dev. Ind. Pharm."},{"key":"10.1016\/j.jconrel.2022.10.024_bb0455","doi-asserted-by":"crossref","first-page":"1798","DOI":"10.1021\/acs.biomac.9b00214","article-title":"Rifampicin nanoformulation enhances treatment of tuberculosis in zebrafish","volume":"20","author":"Trousil","year":"2019","journal-title":"Biomacromolecules"},{"key":"10.1016\/j.jconrel.2022.10.024_bb0460","doi-asserted-by":"crossref","DOI":"10.3389\/fbioe.2022.941077","article-title":"Recent advances in PLGA micro\/nanoparticle delivery systems as novel therapeutic approach for drug-resistant tuberculosis","volume":"10","author":"Shao","year":"2022","journal-title":"Front. Bioeng. Biotechnol."}],"container-title":["Journal of Controlled Release"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365922006940?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365922006940?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T00:41:12Z","timestamp":1777509672000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168365922006940"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12]]},"references-count":92,"alternative-id":["S0168365922006940"],"URL":"https:\/\/doi.org\/10.1016\/j.jconrel.2022.10.024","relation":{},"ISSN":["0168-3659"],"issn-type":[{"value":"0168-3659","type":"print"}],"subject":[],"published":{"date-parts":[[2022,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"In silico identification and synthesis of a multi-drug loaded MOF for treating tuberculosis","name":"articletitle","label":"Article Title"},{"value":"Journal of Controlled Release","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jconrel.2022.10.024","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}